Microvascular Dysfunction
13
3
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
23%
3 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (13)
Palmitic Acid and Human Microvascular Function
The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease
Nailfold Capillaroscopy and Endothelial Biomarkers in Healthcare Workers Exposed to Chronic Low-Dose Ionizing Radiation
Comprehensive Coronary Physiology in Patients With Angina With Nonobstructive Coronary Arteries - Czech Republic
Cheese Consumption and Human Microvascular Function
Cardiac Magnetic Resonance Stress-perfusion Study in Patinets with Fontan Circulation
Microvascular Dysfunction in Adults with Congenital Heart Disease and the Effect of Exercise Training
Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registry
Empagliflozin for Peripheral Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
Association Between Microvascular Resistance and Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy
Elucidating the Role of Microvascular Dysfunction in Heart Disease in Women
Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.
Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus